Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2009-09-11
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 28
- Registration Number
- NCT00847405
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00841659
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Amlodipine 10 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 28
- Registration Number
- NCT00841542
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 50
- Registration Number
- NCT00841698
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Amlodipine 10 mg Tablets Under Fed Conditions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 28
- Registration Number
- NCT00841815
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
Cilostazol 50 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 30
- Registration Number
- NCT00839930
- Locations
- 🇺🇸
PRACS Institute Ltd., East Grand Forks, Minnesota, United States
🇺🇸PRACS Institute, Ltd., Fargo, North Dakota, United States
Buspirone Hydrochloride 30mg Tablets, Non-Fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00840398
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Buspirone Hydrochloride 30mg Tablets, Fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 70
- Registration Number
- NCT00840606
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Meloxicam 15 mg Tablets Under Non-Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 28
- Registration Number
- NCT00840879
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
Cefprozil 500 mg Tablets Under Fed Conditions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 39
- Registration Number
- NCT00840866
- Locations
- 🇺🇸
Gateway Medical Research, Saint Charles, Missouri, United States